1089921

Michael R Sperling, M.D. — FEI 3006649002

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 1, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)